Interpace Biosciences services

Molecular testing at Interpace Diagnostics^® is performed in our high-tech laboratories led by pioneers in molecular diagnostics. Our laboratory, located in Pittsburgh, Pennsylvania is Clinical Laboratory Improvement Amendment (CLIA) certified and College of American Pathologists (CAP) accredited. Additionally, we house one of the largest repositories of pancreatic cyst samples that have undergone the rigors of molecular testing.

Interpace Pharma Solutions is a Companion Diagnostics facilitator.  We work in partnership with the pharma sponsor and reagent provider to generate data for regulatory filing.  We have executed over 30 immuno-oncology studies, including inter laboratory reproducibility studies and prospective enrollment studies using IHC and RT PCR technologies.

Our tests assist healthcare providers in distinguishing between patients at risk for progression to cancer versus non-progressions. Thus, as part of a comprehensive diagnostic and treatment plan, our tests allow healthcare providers to determine whether surgery or active surveillance is most appropriate.

At Interpace Diagnostics, we are committed to providing patients with access to personalized medicine, regardless of their personal financial situation.

The NAVIGATOR Patient Support program is a resource to help guide patients through the process of obtaining and paying for molecular testing. The NAVIGATOR team will help provide benefits analysis and investigation, explain the available financial support options, and address any questions about Interpace Diagnostics tests and services.